NBTK.DE vs. SC0T.DE
NBTK.DE (Invesco Nasdaq Biotech UCITS ETF) and SC0T.DE (Invesco European Health Care Sector UCITS ETF) are both Health & Biotech Equities funds from Invesco - NBTK.DE tracks the Nasdaq Biotechnology while SC0T.DE tracks the STOXX® Europe 600 Optimised Health Care. Both are passively managed. Over the past 5 years, NBTK.DE returned 5.63%/yr vs 4.81%/yr for SC0T.DE. A 0.58 correlation means they provide meaningful diversification when combined. NBTK.DE charges 0.40%/yr vs 0.20%/yr for SC0T.DE.
Performance
NBTK.DE vs. SC0T.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NBTK.DE achieves a 4.27% return, which is significantly higher than SC0T.DE's -3.57% return.
NBTK.DE
- 1D
- 2.92%
- 1M
- 0.38%
- YTD
- 4.27%
- 6M
- 3.76%
- 1Y
- 39.20%
- 3Y*
- 9.94%
- 5Y*
- 5.63%
- 10Y*
- —
SC0T.DE
- 1D
- 2.93%
- 1M
- 0.25%
- YTD
- -3.57%
- 6M
- -2.50%
- 1Y
- 2.66%
- 3Y*
- 2.80%
- 5Y*
- 4.81%
- 10Y*
- 5.80%
NBTK.DE vs. SC0T.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 4.27% | 18.60% | 4.57% | 2.51% | -6.11% | 7.46% | 14.59% | 17.24% |
SC0T.DE Invesco European Health Care Sector UCITS ETF | -3.57% | 8.45% | 6.96% | 5.35% | -7.56% | 25.20% | -1.18% | 10.08% |
Correlation
The correlation between NBTK.DE and SC0T.DE is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.59 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.55 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2019 | 0.58 |
The correlation between NBTK.DE and SC0T.DE has been stable across timeframes, ranging from 0.54 to 0.59 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NBTK.DE vs. SC0T.DE — Risk / Return Rank
NBTK.DE
SC0T.DE
NBTK.DE vs. SC0T.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Invesco European Health Care Sector UCITS ETF (SC0T.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NBTK.DE | SC0T.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.83 | ||
| Sortino ratioReturn per unit of downside risk | +2.46 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.05 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 6.16 | 0.24 | +5.92 |
| Martin ratioReturn relative to average drawdown | 17.06 | 0.56 | +16.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NBTK.DE | SC0T.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.03 | 0.20 | +1.83 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | 0.32 | -0.05 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.37 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.63 | -0.21 |
Drawdowns
NBTK.DE vs. SC0T.DE - Drawdown Comparison
The maximum NBTK.DE drawdown since its inception was -30.99%, which is greater than SC0T.DE's maximum drawdown of -26.52%. Use the drawdown chart below to compare losses from any high point for NBTK.DE and SC0T.DE.
Loading charts...
Drawdown Indicators
| NBTK.DE | SC0T.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.99% | -26.52% | -4.47% |
Max Drawdown (1Y)Largest decline over 1 year | -6.24% | -12.87% | +6.63% |
Max Drawdown (3Y)Largest decline over 3 years | -29.35% | -21.67% | -7.68% |
Max Drawdown (5Y)Largest decline over 5 years | -30.99% | -21.67% | -9.32% |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.52% | — |
Current DrawdownCurrent decline from peak | -1.44% | -9.59% | +8.15% |
Average DrawdownAverage peak-to-trough decline | -10.62% | -6.03% | -4.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.26% | 5.58% | -3.32% |
Volatility
NBTK.DE vs. SC0T.DE - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) has a higher volatility of 6.41% compared to Invesco European Health Care Sector UCITS ETF (SC0T.DE) at 5.31%. This indicates that NBTK.DE's price experiences larger fluctuations and is considered to be riskier than SC0T.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NBTK.DE | SC0T.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.41% | 5.31% | +1.10% |
Volatility (6M)Calculated over the trailing 6-month period | 14.11% | 11.43% | +2.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.00% | 15.98% | +3.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.30% | 14.84% | +5.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.05% | 15.39% | +6.66% |
NBTK.DE vs. SC0T.DE - Expense Ratio Comparison
NBTK.DE has a 0.40% expense ratio, which is higher than SC0T.DE's 0.20% expense ratio.
Dividends
NBTK.DE vs. SC0T.DE - Dividend Comparison
Neither NBTK.DE nor SC0T.DE has paid dividends to shareholders.
Frequently Asked Questions
NBTK.DE and SC0T.DE have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SC0T.DE is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SC0T.DE is cheaper with a 0.20% expense ratio, compared with 0.40% for NBTK.DE.
NBTK.DE tracks Nasdaq Biotechnology, while SC0T.DE tracks STOXX® Europe 600 Optimised Health Care. Their fees differ too: 0.40% for NBTK.DE and 0.20% for SC0T.DE.
Find the right allocation for NBTK.DE and SC0T.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer